CONCLUSIONS:
To our knowledge, this is the first study to compare molecular signatures of nerves repaired using minimal and significant tension. Further study of these upand downregulated genes could help identify targets for optimizing nerve healing and regeneration. Similar methodologies using RNA-Seq could be applied to studying neuroma in continuity and other nerve pathology that often requires intervention.
Lipovol: A Free and Validated Software for Measuring Fat Graft Volume Retention in the Breast With Magnetic Resonance Imaging

Presenter: Mathilde Nejrup Hemmingsen, BMSc
Co-Authors: Mathias Orholt, BMSc; Felix C. Muller, MD; Bo S. Rasmussen, MD, PhD; Jens Jorgen Elberg, MD; Krzysztof Tadeusz Drzewiecki, MD, DMSci; Peter Viktor Vester-Glowinski, MD, PhD; Mikkel Herly, MD Affiliation: Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
BACKGROUND: Fat graft volume retention in the breast is difficult to measure because the graft is dispersed in the breast tissue preventing delineation of the graft. 1 The authors present a new automated software (Lipovol) to measure fat graft volume retention in the breast based on magnetic resonance imaging (MRI) scans and a validation study of the software's accuracy.
METHODS:
The Lipovol software calculates fat graft volume retention in the breast using 2 MRI scans of the same patient recorded before the surgery and after a follow-up period (eg, a preoperative scan and a 4-month postoperative scan). The software works by guiding the user to align the 2 MRI scans in a matrix using osseous pointers. Thereafter, the software can delineate the breasts with an algorithm and calculate the difference in breast volume. The difference in breast volume is then divided by the injected fat graft volume to calculate the fat graft volume retention. The validation study was designed to test the accuracy of the software in measuring changes in breast volume. It was performed on 28 patients with known changes in breast volume: 14 patients who received silicone implants and 14 patients who received fat grafting to the breast examined right after surgery. The accuracy of the software was calculated as the difference between the known change in breast volume (ie, implant volume or fat graft volume) and the measured change in breast volume. The measurements were performed by 4 blinded observers with a total of 224 individual measurements and 96 repeated measurements.
RESULTS:
The software measured the fat graft volumes with a systematic error of only 5.7% (95% confidence interval [CI], 3.3%-8.0%) overestimation and an average interobserver variation of 20.8 ml (95% CI, 17.6-24.0 ml). The change in breast volume after a breast augmentation with breast implants was associated with a significantly higher systematic error of 24% (95% CI, 17%-31%) overestimation (P < 0.001), but the interobserver variation of 19.8 ml (95% CI, 15.2-24.4 ml) was similar to what was seen in the fat grafting patients.
CONCLUSION:
The Lipovol software was very accurate in predicting the known volume changes after breast augmentations, especially when measuring changes in breast volume after fat grafting. The software will be made freely available in MeVisLab (www.mevislab.de), and we propose this software as the new gold standard technique for measuring fat graft retention in the breast.
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